Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study

AIM: Cardioversion can rapidly and effectively restore sinus rhythm in patients with persistent atrial fibrillation. Since 2011 dabigatran has been available as an alternative to warfarin to prevent thromboembolic events in patients with non-valvular atrial fibrillation undergoing cardioversion. We...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Pallisgaard, Jannik Langtved, Lindhardt, Tommi Bo, Hansen, Morten Lock, Schjerning, Anne-Marie, Olesen, Jonas Bjerring, Staerk, Laila, Torp-Pedersen, Christian, Gislason, Gunnar Hilmar
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4625957/
https://ncbi.nlm.nih.gov/pubmed/26513589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0141377
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars